IDEXX Laboratories Inc (IDXX) - Total Liabilities
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has total liabilities worth $1.83 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore IDEXX Laboratories Inc (IDXX) equity growth momentum to track the company's year-over-year net asset growth rate.
IDEXX Laboratories Inc - Total Liabilities Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of IDEXX Laboratories Inc to measure how efficiently the company converts operating cash flow to free cash.
IDEXX Laboratories Inc Competitors by Total Liabilities
The table below lists competitors of IDEXX Laboratories Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Itaú Unibanco Holding S.A
F:BVXB
|
Germany | €2.85 Trillion |
|
Itau Unibanco Banco Holding SA
NYSE:ITUB
|
USA | $2.92 Trillion |
|
STMicroelectronics N.V
F:SGMR
|
Germany | €6.96 Billion |
|
Old Dominion Freight Line Inc
NASDAQ:ODFL
|
USA | $1.26 Billion |
|
Rocket Lab USA Inc.
NASDAQ:RKLB
|
USA | $555.57 Million |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
USA | $23.28 Billion |
|
Goodman Group
AU:GMG
|
Australia | AU$6.57 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €7.76 Trillion |
Liability Composition Analysis (1991–2025)
This chart breaks down IDEXX Laboratories Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IDEXX Laboratories Inc (IDXX) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IDEXX Laboratories Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual total liabilities of IDEXX Laboratories Inc from 1991 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.75 Billion | +2.78% |
| 2024-12-31 | $1.70 Billion | -4.35% |
| 2023-12-31 | $1.78 Billion | -16.96% |
| 2022-12-31 | $2.14 Billion | +22.37% |
| 2021-12-31 | $1.75 Billion | +5.14% |
| 2020-12-31 | $1.66 Billion | +0.43% |
| 2019-12-31 | $1.65 Billion | +6.99% |
| 2018-12-31 | $1.55 Billion | -12.49% |
| 2017-12-31 | $1.77 Billion | +7.83% |
| 2016-12-31 | $1.64 Billion | +5.13% |
| 2015-12-31 | $1.56 Billion | +23.08% |
| 2014-12-31 | $1.27 Billion | +77.82% |
| 2013-12-31 | $712.30 Million | +52.41% |
| 2012-12-31 | $467.35 Million | -4.86% |
| 2011-12-31 | $491.22 Million | +52.15% |
| 2010-12-31 | $322.86 Million | +9.84% |
| 2009-12-31 | $293.95 Million | -10.17% |
| 2008-12-31 | $327.24 Million | +24.02% |
| 2007-12-31 | $263.86 Million | +76.26% |
| 2006-12-31 | $149.70 Million | +23.35% |
| 2005-12-31 | $121.37 Million | +4.11% |
| 2004-12-31 | $116.58 Million | +7.36% |
| 2003-12-31 | $108.58 Million | +43.48% |
| 2002-12-31 | $75.68 Million | +6.03% |
| 2001-12-31 | $71.38 Million | -3.61% |
| 2000-12-31 | $74.05 Million | -2.44% |
| 1999-12-31 | $75.90 Million | -8.22% |
| 1998-12-31 | $82.70 Million | +11.31% |
| 1997-12-31 | $74.30 Million | +45.12% |
| 1996-12-31 | $51.20 Million | +53.29% |
| 1995-12-31 | $33.40 Million | +52.51% |
| 1994-12-31 | $21.90 Million | +52.08% |
| 1993-12-31 | $14.40 Million | +54.84% |
| 1992-12-31 | $9.30 Million | +40.91% |
| 1991-12-31 | $6.60 Million | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more